Company / Cash per Share
LEXICON PHARMACEUTICALS, INC. Cash per Share History
FY2013-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Cash per Share
$0.09
FY2025
5-year range
$0.09 / $0.61
FY2021-FY2025
Trend
-76.5%
vs FY2024
Sector context
Sector data unavailable
Latest sector comparison
What the data says
Cash per Share has fluctuated over the past 10 years, ranging from $0.06 in FY2014 to $1.96 in FY2017.
Based on SEC 10-K filings.
0.09 in FY2025 with a 10-year CAGR of -15.5%.
Declined from $0.15 to $0.09 over the past 2 years.
Cash per Share over time
Growth rates
- 3-Year CAGR
- -
- 5-Year CAGR
- -
- 10-Year CAGR
- -15.5%
Key checks
Key Insights
- In FY2025, cash per share decreased 76.5% year-over-year.
- Peak cash per share was recorded in FY2017.
- Lowest cash per share in the period was in FY2014.
Company context
Key Data Points
- Altman Z-Score -1.98 (distress zone, below 1.8 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Cash per ShareValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $0.09 | -76.5% |
| FY2024 | $0.40 | +160.8% |
| FY2023 | $0.15 | -74.6% |
| FY2019 | $0.61 | +35.1% |
| FY2018 | $0.45 | -77.1% |
| FY2017 | $1.96 | +9.0% |
| FY2016 | $1.80 | +251.5% |
| FY2015 | $0.51 | +723.5% |
| FY2014 | $0.06 | -88.6% |
| FY2013 | $0.55 | +250.7% |
As of FY2025 · SEC 10-K Annual Filings · Updated Jun 24, 2026